Get started
Author

Antón Álvarez

Observed names: A. Alvarez, A. Álvarez, Alvarez, A., Anton Alvarez, Antòn X. Álvarez, Antón Alvarez, Antön Alvarez
ORCID: 0000-0002-2827-1748
Observed ORCID: 0000-0002-2827-1748
OpenAlex ID: A5113580570
Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease
2006 · Antón Álvarez, Ramón Cacabelos, et al. · Neurobiology of Aging · 286
Pharmacological treatment of Alzheimer disease: From psychotropic drugs and cholinesterase inhibitors to pharmacogenomics
2000 · Cacabelos, R., Alvarez, A., et al. · Drugs of today · 81
Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use
2020 · Svetlana I. Gavrilova, Anton Alvarez · Medicinal Research Reviews · 61
Apathy and APOE4 are associated with Reduced BDNF Levels in Alzheimer's Disease
2014 · Antón Álvarez, Manuel Aleixandre, et al. · Journal of Alzheimer s Disease · 61
Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants
2010 · Ramón Cacabelos, Lucía Fernández-Novoa, et al. · Pharmaceuticals · 47
PDF
Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin
2023 · Konrad Rejdak, Halina Sienkiewicz‐Jarosz, et al. · Medicinal Research Reviews · 44
PDF
A Retrospective, Multi-Center Cohort Study Evaluating the Severity- Related Effects of Cerebrolysin Treatment on Clinical Outcomes in Traumatic Brain Injury
2015 · Dafin Muresanu, Alexandru Ciurea, et al. · CNS & Neurological Disorders - Drug Targets · 42
A pharmacogenomic approach to Alzheimer’s disease
2000 · R. Cacabelos, A. Alvarez, et al. · Acta Neurologica Scandinavica · 42
VaD - An Integrated Framework for Cognitive Rehabilitation
2018 · Maria Balea, Dafin Muresanu, et al. · CNS & Neurological Disorders - Drug Targets · 9
Neuroprotective role of S12024 against neurodegeneration in the rat dentate gyrus
1998 · José Javier Miguel-Hidalgo, Begoña Vecino, et al. · European Neuropsychopharmacology · 9
Anapsos: Neuroimmunotrophic Treatment in Alzheimer Disease and Neurodegenerative Disorders
1997 · Antön Alvarez, José J. Miguel‐Hidalgo, et al. · CNS Drug Reviews · 9
P1‐246: Synergistic treatment effects with Cerebrolysin and donepezil: Results from a randomized, double‐blind, multicenter trial to compare safety and efficacy of Cerebrolysin, donepezil and a combination treatment in patients with probable Alzheimer's disease
2009 · Edith Doppler, Anton Alvarez, et al. · Alzheimer s & Dementia · 3
PDF
P2–402: Double–blind, placebo–controlled study of three different dosages of cerebrolysin in patients with mild to moderate Alzheimer's disease
2006 · Anton Alvarez, Marta Laredo, et al. · Alzheimer s & Dementia · 3
P3‐396: Cerebrolysin and Combination Therapy Enhance Serum Bdnf in Ad Patients
2014 · Anton Alvarez, Olalla Iglesias, et al. · Alzheimer s & Dementia · 2
P2‐385: Cerebrolysin reduces TNF‐alpha and soluble TNF receptor‐I levels in the serum of Alzheimer's disease patients
2008 · Anton Alvarez, Carolina Sampedro, et al. · Alzheimer s & Dementia · 2
Dose-dependent effects of anapsos in senile dementia patients: A double-blind, randomized, placebo controlled study
2000 · Anton Alvarez, Victor Pichel, et al. · Neurobiology of Aging · 2
P1‐244: Combined treatment with cerebrolysin and donepezil in mild to moderate alzheimer's disease: Results of a double‐blind, randomized clinical trial
2009 · Anton Alvarez, Ramon Cacabelos, et al. · Alzheimer s & Dementia · 1
PDF
P1‐272: Opposite effects of cerebrolysin on serum TNF‐alpha and IGF‐I levels in Alzheimer's disease
2009 · Anton Alvarez, Carolina Sampedro, et al. · Alzheimer s & Dementia · 1
PDF
Anapsos Improves Learning and Memory in Rats with βA(1–28) Deposits Into the Hippocampus
1998 · Antón Alvarez, José Javier Miguel-Hidalgo, et al. · Advances in behavioral biology · 1
Brain Mapping and Transcranial Doppler Ultrasonography in Alzheimer Disease Drug Monitoring
1997 · Ramón Cacabelos, José Caamaño, et al. · Birkhäuser Boston eBooks · 1
P3‐030: Cognitive Correlates of Serum Vegf Are Modulated by Apoe in Advanced Ad
2019 · Anton Alvarez, Irene Alvarez, et al. · Alzheimer s & Dementia
P1‐048: Serum Vegf Levels Are Associated With Cognition and Functioning in Ad: Influence of Treatment With Cerebrlysin and Donepezil
2018 · Anton Alvarez, Irene Alvarez, et al. · Alzheimer s & Dementia
[p4–117]: Serum Vegf Increases With Disease Severity and Is a Positive Correlate for Cognition in Apoe4 Carriers With Advanced Ad
2017 · Anton Alvarez, Irene Alvarez, et al. · Alzheimer s & Dementia
PDF
P1‐062: Serum BDNF Levels and Cognitive Performance in Alzheimer's Disease Patients: Influence of Apathy and Apoe4 Status
2016 · Anton Alvarez, Irene Alvarez, et al. · Alzheimer s & Dementia
P3‐448: Neurotrophic and cholinergic treatment in Alzheimer's disease: Results of a randomized clinical trial
2010 · Anton Alvarez, Carolina Sampedro, et al. · Alzheimer s & Dementia
Works count: 39
Citation count: 707
H-index: 9
I10-index: 8
Year
Topic
Type